Free Trial

Johnson & Johnson (JNJ) SEC Filings & 10K Form

$156.03
+3.68 (+2.42%)
(As of 02:26 PM ET)

Recent Johnson & Johnson SEC Filings

DateFilerForm TypeView
07/17/2024
7:14 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
4:48 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:18 PM
Johnson & Johnson (Filer)
Form 11-K/A
06/24/2024
3:43 PM
Johnson & Johnson (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/24/2024
3:42 PM
Johnson & Johnson (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/06/2024
4:07 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:07 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:10 PM
Johnson & Johnson (Filer)
Form SD
Specialized Disclosure Report  
05/21/2024
9:43 AM
Johnson & Johnson (Filer)
Form CERT
05/20/2024
4:17 PM
Johnson & Johnson (Filed by)
Kenvue Inc. (Subject)
Form SC 13G/A
05/20/2024
3:34 PM
Johnson & Johnson (Filer)
Form 8-A12B
05/20/2024
8:31 AM
Johnson & Johnson (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
05/17/2024
10:21 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
5:05 AM
Johnson & Johnson (Filer)
Form 424B5
05/13/2024
7:36 AM
Johnson & Johnson (Filer)
Form 424B5
05/10/2024
4:14 PM
Johnson & Johnson (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
05/01/2024
6:00 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
6:09 AM
Johnson & Johnson (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
4:05 PM
Doudna Jennifer A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:05 PM
Johnson & Johnson (Issuer)
Johnson Paula A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:05 PM
Johnson & Johnson (Issuer)
Joly Hubert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Johnson & Johnson (Issuer)
McClellan Mark B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Johnson & Johnson (Issuer)
WEINBERGER MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Johnson & Johnson (Issuer)
MULCAHY ANNE M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Adamczyk Darius (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Johnson & Johnson (Issuer)
West Nadja (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Beckerle Mary C (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
11:16 AM
Johnson & Johnson (Filer)
Form 8-K/A
04/16/2024
6:06 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
4:05 PM
Contineum Therapeutics, Inc. (Issuer)
Johnson & Johnson (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/10/2024
4:12 PM
Contineum Therapeutics, Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G
04/05/2024
4:29 PM
Johnson & Johnson (Filed by)
Shockwave Medical, Inc. (Subject)
Form DFAN14A
03/27/2024
8:48 AM
Johnson & Johnson (Subject)
National Legal & Policy Center (Filed by)
Form PX14A6G
03/13/2024
3:28 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2024
3:36 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
6:42 AM
Johnson & Johnson (Filer)
Form ARS
03/13/2024
6:35 AM
Johnson & Johnson (Filer)
Form DEF 14A
03/13/2024
6:37 AM
Johnson & Johnson (Filer)
Form DEFA14A
03/13/2024
6:39 AM
Johnson & Johnson (Filer)
Form DEFA14A
Biden’s parting shot at AI could create the perfect buying opportunity (Ad)

Last week, we saw the largest single drop in semiconductor stock prices since the COVID crisis. All dropped nearly 10% or more.

What to do now?
03/06/2024
2:42 PM
CVRx, Inc. (Issuer)
Johnson & Johnson (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:58 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:54 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:12 PM
Johnson & Johnson (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
4:23 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
02/15/2024
3:53 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Hait William (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Hait William (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Hait William (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
11:55 AM
Johnson & Johnson (Subject)
McEvoy Ashley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
11:35 AM
Johnson & Johnson (Subject)
Taubert Jennifer L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2024
3:24 PM
Johnson & Johnson (Subject)
McEvoy Ashley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:07 PM
BiomX Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G/A
02/02/2024
3:52 PM
CVRx, Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G/A
02/02/2024
3:32 PM
Johnson & Johnson (Filed by)
Johnson & Johnson (Filed by)
Nanobiotix S.A. (Subject)
Form SC 13G/A
01/30/2024
11:46 AM
Johnson & Johnson (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/29/2024
3:50 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/24/2024
11:51 AM
Johnson & Johnson (Filed by)
Kenvue Inc. (Subject)
Form SC 13G
01/23/2024
6:45 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
4:08 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/08/2024
4:22 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/08/2024
7:22 AM
Johnson & Johnson (Filer)
Form DEFA14A
12/08/2023
3:33 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2023
4:17 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:42 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
What comes next after the attempt on Trump's life... (Ad)

After this weekend’s attempt on Trump's life... it seems all but a lock for him to return to the White House. Now "only an ‘October Surprise’ can swing the presidential election," writes Doug Schoen, of The Hill.

Click here to learn about 2024’s real October Election Surprise
12/05/2023
6:52 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2023
3:30 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
3:56 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:36 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
3:48 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
6:33 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
3:36 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
6:46 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
4:02 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:JNJ) was last updated on 7/24/2024 by MarketBeat.com Staff

From Our Partners